View Older Stories View More Recent Stories

Aug 4, 2025 12:58PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $155 at Guggenheim
Aug 4, 2025 09:05AM Praxis Precision Medicines (PRAX) Misses Q2 EPS by 6c
Aug 4, 2025 08:10AM Praxis reports positive seizure reduction results from vormatrigine trial
Jul 18, 2025 06:55AM H.C. Wainwright Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Jul 17, 2025 08:01AM Praxis receives FDA breakthrough therapy designation for relutrigine
Jul 10, 2025 09:45AM Piper Sandler Reiterates OW Rating on Praxis Precision Medicines (PRAX) Post NYC Investor Dinner
Jun 2, 2025 08:55AM Oppenheimer Assumes Praxis Precision Medicines Inc. (PRAX) at Outperform
May 12, 2025 07:58AM Piper Sandler: 'We Remain Bullish on Praxis Precision Medicines Inc. (PRAX)'
May 7, 2025 04:30AM Chardan Capital Markets Starts Praxis Precision Medicines Inc. (PRAX) at Buy
May 5, 2025 08:07AM Praxis Precision Medicines (PRAX) Highlights DEE Clinical Program Updates at Virtual Investor Event
May 5, 2025 05:18AM Guggenheim on Praxis Precision Medicines Inc. (PRAX): 'remains one of our Top Picks for 2025'
May 2, 2025 04:26PM Praxis Precision Medicines (PRAX) Misses Q1 EPS by 42c
Mar 4, 2025 05:00PM Praxis Precision Medicines (PRAX) announces inducement grants
Feb 28, 2025 03:02PM Praxis Precision Medicines Inc. (PRAX) PT Lowered to $61 at TD Cowen
Feb 28, 2025 11:08AM Praxis Precision Medicines Inc. (PRAX) PT Lowered to $85 at Truist Securities
Feb 28, 2025 08:01AM Praxis Precision Medicines (PRAX) IDMC has recommended Essential3 study be stopped for futility
Feb 11, 2025 04:16AM Deutsche Bank Starts Praxis Precision Medicines Inc. (PRAX) at Buy
Jan 22, 2025 11:34AM Jefferies Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Jan 21, 2025 10:56AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $175 at Truist; 'Incrementally Positive On Ph3 ESSENTIAL3'
Jan 3, 2025 08:23AM Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies
Jan 2, 2025 12:51PM Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'
Dec 23, 2024 04:19PM Praxis Precision Medicines (PRAX) Files Mixed Shelf
Dec 11, 2024 07:38AM Piper Sandler on Praxis Precision Medicines Inc. (PRAX): '2025 a Key Year to Drive Substantial Shares Gains'
Dec 11, 2024 06:12AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $305 at Jefferies
Nov 12, 2024 07:25AM Piper Sandler Reiterates Overweight Rating on Praxis Precision Medicines Inc. (PRAX)
Nov 6, 2024 03:02PM Guggenheim Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Nov 6, 2024 07:35AM Praxis Precision Medicines (PRAX) Misses Q3 EPS by 76c
Oct 14, 2024 02:35PM Oppenheimer Reiterates Outperform Rating on Praxis Precision Medicines Inc. (PRAX)
Oct 7, 2024 07:14AM Piper Sandler Reiterates Overweight Rating on Praxis Precision Medicines Inc. (PRAX)
Oct 3, 2024 03:10PM Praxis Precision Medicines (PRAX) spreader active in November 65 and 90 calls as share price up 9.6%
Oct 3, 2024 06:09AM Truist Securities Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Sep 24, 2024 08:39AM TD Cowen Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Sep 10, 2024 06:41AM H.C. Wainwright Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Sep 7, 2024 08:00PM Here's the list of biotech stocks that have key data catalysts in 2025
Sep 4, 2024 07:36AM H.C. Wainwright Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Sep 4, 2024 07:12AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $151 at Needham
Sep 3, 2024 04:10PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $143 at Oppenheimer
Sep 3, 2024 02:56PM TD Cowen Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Sep 3, 2024 01:57PM Guggenheim Defending Praxis Precision Medicines Inc. (PRAX): 'we are buyers, especially on the current weakness'
Sep 3, 2024 10:20AM Truist Securities Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Sep 3, 2024 07:50AM Truist Securities Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
Sep 3, 2024 07:31AM Praxis Precision Medicines (PRAX) announces positive topline results from the EMBOLD study in SCN2A and 8A developmental epilepsies, highlighting the disease-modifying potential of relutrigine
Aug 21, 2024 07:42AM Piper Sandler Reiterates Overweight Rating on Praxis Precision Medicines Inc. (PRAX)
Aug 14, 2024 06:42AM Praxis Precision Medicines Inc. (PRAX) PT Raised to $120 at H.C. Wainwright
Aug 13, 2024 04:44PM Praxis Precision Medicines Inc. (PRAX) PT Raised to $170 at Guggenheim
Aug 5, 2024 06:01AM Oppenheimer Starts Praxis Precision Medicines Inc. (PRAX) at Outperform
Jul 18, 2024 07:50AM Piper Sandler Reiterates Overweight Rating on Praxis Precision Medicines Inc. (PRAX)
Jul 1, 2024 07:19AM Piper Sandler Reiterates Overweight Rating on Praxis Precision Medicines Inc. (PRAX)
Jun 17, 2024 07:53AM Piper Sandler Reiterates Overweight Rating on Praxis Precision Medicines Inc. (PRAX)
View More Recent Stories View Older Stories